Evidence map›Paper›PMID 39458606›Full record

ReviewPharmaceutics2024

Annatto (

Vitória Regina Pereira da Silva, Natália Ornelas Martins, Carolina Ramos Dos Santos, Elysa Beatriz de Oliveira Damas, Paula Lauane Araujo, Gabriella de Oliveira Silva, Graziella Anselmo Joanitti, Marcella Lemos Brettas Carneiro

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Bixin fromACS omega · 2025
    Article
  4. Nano-Based Technology in Glioblastoma.Molecules (Basel, Switzerland) · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vitória Regina Pereira da SilvaLaboratory of Bioactive Compounds and Nanobiotechnology (LCBNano), Campus Darcy Ribeiro, University of Brasilia, Brasilia 70910-900, Brazil.
Natália Ornelas MartinsLaboratory of Bioactive Compounds and Nanobiotechnology (LCBNano), Campus Darcy Ribeiro, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0001-5643-7154
Carolina Ramos Dos SantosLaboratory of Bioactive Compounds and Nanobiotechnology (LCBNano), Campus Darcy Ribeiro, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0003-0677-7745
Elysa Beatriz de Oliveira DamasLaboratory of Bioactive Compounds and Nanobiotechnology (LCBNano), Campus Darcy Ribeiro, University of Brasilia, Brasilia 70910-900, Brazil.
Paula Lauane AraujoLaboratory of Bioactive Compounds and Nanobiotechnology (LCBNano), Campus Darcy Ribeiro, University of Brasilia, Brasilia 70910-900, Brazil.
Gabriella de Oliveira SilvaLaboratory of Bioactive Compounds and Nanobiotechnology (LCBNano), Campus Darcy Ribeiro, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0009-0006-3587-7728
Graziella Anselmo JoanittiLaboratory of Bioactive Compounds and Nanobiotechnology (LCBNano), Campus Darcy Ribeiro, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0002-6888-1284
Marcella Lemos Brettas CarneiroLaboratory of Bioactive Compounds and Nanobiotechnology (LCBNano), Campus Darcy Ribeiro, University of Brasilia, Brasilia 70910-900, Brazil.ORCID 0000-0002-6165-0969

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001Foundation for Research Support of the Federal District 001National Council for Scientific and Technological Development 001Universidade de Brasília 001
6 · The paper itself

Abstract

Plants are a source of valuable organic chemical compounds with complex structures rich in therapeutic activities. The encapsulation of compounds in nanostructured systems is an alternative to avoid limitations, such as instability and low solubility, and to promote therapeutic use. The objective of the present review was to summarize the data in the literature on the physicochemical characteristics, biomedical efficacy, and toxicity of nanostructures containing extracts and oils obtained from annatto (

Indexed as

annattobiomedical applicationBixa orellanaextractnanotechnologyoiltoxicity

Identifiers

PMID39458606
PMCPMC11510392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.